Literature DB >> 30470628

Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration.

Irene de Lázaro1, Acelya Yilmazer2, Yein Nam1, Sara Qubisi1, Fazilah Maizatul Abdul Razak1, Hans Degens3, Giulio Cossu4, Kostas Kostarelos5.   

Abstract

Overexpression of Oct3/4, Klf4, Sox2, and c-Myc (OKSM) transcription factors can de-differentiate adult cells in vivo. While sustained OKSM expression triggers tumorigenesis through uncontrolled proliferation of toti- and pluripotent cells, transient reprogramming induces pluripotency-like features and proliferation only temporarily, without teratomas. We sought to transiently reprogram cells within mouse skeletal muscle with a localized injection of plasmid DNA encoding OKSM (pOKSM), and we hypothesized that the generation of proliferative intermediates would enhance tissue regeneration after injury. Intramuscular pOKSM administration rapidly upregulated pluripotency (Nanog, Ecat1, and Rex1) and early myogenesis genes (Pax3) in the healthy gastrocnemius of various strains. Mononucleated cells expressing such markers appeared in clusters among myofibers, proliferated only transiently, and did not lead to dysplasia or tumorigenesis for at least 120 days. Nanog was also upregulated in the gastrocnemius when pOKSM was administered 7 days after surgically sectioning its medial head. Enhanced tissue regeneration after reprogramming was manifested by the accelerated appearance of centronucleated myofibers and reduced fibrosis. These results suggest that transient in vivo reprogramming could develop into a novel strategy toward the acceleration of tissue regeneration after injury, based on the induction of transiently proliferative, pluripotent-like cells in situ. Further research to achieve clinically meaningful functional regeneration is warranted.
Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  OKSM; in vivo reprogramming; muscle; plasmid DNA; pluripotency; regeneration

Mesh:

Year:  2018        PMID: 30470628      PMCID: PMC6318817          DOI: 10.1016/j.ymthe.2018.10.014

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  76 in total

Review 1.  Myogenic progenitor cells and skeletal myogenesis in vertebrates.

Authors:  Margaret Buckingham
Journal:  Curr Opin Genet Dev       Date:  2006-08-22       Impact factor: 5.578

2.  ISMuLT Guidelines for muscle injuries.

Authors:  Nicola Maffulli; Francesco Oliva; Antonio Frizziero; Gianni Nanni; Michele Barazzuol; Alessio Giai Via; Carlo Ramponi; Paola Brancaccio; Gianfranco Lisitano; Diego Rizzo; Marco Freschi; Stefano Galletti; Gianluca Melegati; Giulio Pasta; Vittorino Testa; Alessandro Valent; Angelo Del Buono
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

Review 3.  Biological approaches to improve skeletal muscle healing after injury and disease.

Authors:  Burhan Gharaibeh; Yuri Chun-Lansinger; Tanya Hagen; Sheila Jean McNeill Ingham; Vonda Wright; Freddie Fu; Johnny Huard
Journal:  Birth Defects Res C Embryo Today       Date:  2012-03

4.  MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.

Authors:  Shuichi Watanabe; Hiroyuki Hirai; Yoko Asakura; Christopher Tastad; Mayank Verma; Charles Keller; James R Dutton; Atsushi Asakura
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

5.  Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

Authors:  Yosef Buganim; Dina A Faddah; Albert W Cheng; Elena Itskovich; Styliani Markoulaki; Kibibi Ganz; Sandy L Klemm; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

6.  Heart repair by reprogramming non-myocytes with cardiac transcription factors.

Authors:  Kunhua Song; Young-Jae Nam; Xiang Luo; Xiaoxia Qi; Wei Tan; Guo N Huang; Asha Acharya; Christopher L Smith; Michelle D Tallquist; Eric G Neilson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  Nature       Date:  2012-05-13       Impact factor: 49.962

7.  Salamander limb regeneration involves the activation of a multipotent skeletal muscle satellite cell population.

Authors:  Jamie I Morrison; Sara Lööf; Pingping He; András Simon
Journal:  J Cell Biol       Date:  2006-01-30       Impact factor: 10.539

8.  Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model.

Authors:  Tomoyuki Nakasa; Masakazu Ishikawa; Ming Shi; Hayatoshi Shibuya; Nobuo Adachi; Mitsuo Ochi
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

9.  Sources for skeletal muscle repair: from satellite cells to reprogramming.

Authors:  Dario Sirabella; Luciana De Angelis; Libera Berghella
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-01-12       Impact factor: 12.910

10.  In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors.

Authors:  Açelya Yilmazer; Irene de Lázaro; Cyrill Bussy; Kostas Kostarelos
Journal:  J Vis Exp       Date:  2013-12-17       Impact factor: 1.355

View more
  5 in total

1.  Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming.

Authors:  Irene de Lázaro; Giulio Cossu; Kostas Kostarelos
Journal:  EMBO Mol Med       Date:  2017-06       Impact factor: 12.137

2.  Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state.

Authors:  Thomas Kisby; Irene de Lázaro; Maria Stylianou; Giulio Cossu; Kostas Kostarelos
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

3.  Transcription Factor Reprogramming in the Inner Ear: Turning on Cell Fate Switches to Regenerate Sensory Hair Cells.

Authors:  Amrita A Iyer; Andrew K Groves
Journal:  Front Cell Neurosci       Date:  2021-03-29       Impact factor: 5.505

Review 4.  RNA-Based Strategies for Cell Reprogramming toward Pluripotency.

Authors:  Anaëlle Bailly; Ollivier Milhavet; Jean-Marc Lemaitre
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

5.  Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

Authors:  Elena Melendez; Dafni Chondronasiou; Lluc Mosteiro; Jaime Martínez de Villarreal; Marcos Fernández-Alfara; Cian J Lynch; Dirk Grimm; Francisco X Real; José Alcamí; Núria Climent; Federico Pietrocola; Manuel Serrano
Journal:  Development       Date:  2022-04-22       Impact factor: 6.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.